The World Health Organization halted two trials of vaginal microbicides due to safety concerns, but research on promising microbicides must continue to prevent HIV infections.
In South Africa, 22 women in a gel trial contracted HIV, prompting an investigation.
Male circumcision trials in Kenya and Uganda show a significant reduction in HIV risk, with potential to prevent thousands of infections.
Studies on treating herpes to slow HIV transmission are ongoing.
HIV dementia is prevalent in sub-Saharan Africa, highlighting the urgent need for medication access.
Malawi faces challenges in HIV/AIDS law enforcement but has made progress in ARV treatment.
Valacyclovir shows promise in reducing HIV transmission by targeting
